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Abstract: Psychotherapy has proven to be effective for a wide range of mental health problems.
However, not all patients respond to the treatment as expected (not-on-track patients). Routine
outcome monitoring (ROM) and measurement-based care (MBC), which consist of monitoring
patients between appointments and using this data to guide the intervention, have been shown to be
particularly useful for these not-on-track patients. Traditionally, though, ROM and MBC have been
challenging, due to the difficulties associated with repeated monitoring of patients and providing
real-time feedback to therapists. The use of information and communication technologies (ICTs)
might help reduce these challenges. Therefore, we systematically reviewed evidence regarding the
use of ICTs for ROM and MBC in face-to-face psychological interventions for mental health problems.
The search included published and unpublished studies indexed in the electronic databases PubMed,
PsycINFO, and SCOPUS. Main search terms were variations of the terms “psychological treatment”,
“progress monitoring or measurement-based care”, and “technology”. Eighteen studies met eligibility
criteria. In these, ICTs were frequently handheld technologies, such as smartphone apps, tablets,
or laptops, which were involved in the whole process (assessment and feedback). Overall, the use
of technology for ROM and MBC during psychological interventions was feasible and acceptable.
In addition, the use of ICTs was found to be effective, particularly for not-on-track patients, which is
consistent with similar non-ICT research. Given the heterogeneity of reviewed studies, more research
and replication is needed to obtain robust findings with different technological solutions and to
facilitate the generalization of findings to different mental health populations.
Keywords: information and communication technologies; outcome monitoring; therapist feedback;
measurement-based care; mental health
1. Introduction
The effectiveness of psychotherapy for the treatment of mental disorders has been supported by
an impressive amount of evidence. However, some patients do not respond to treatment as expected,
either because they do not show an improvement during the intervention or they discontinue it,
or because they show a deterioration [1,2]. There might be several reasons explaining individual
differences in response to psychological treatments, including unchallengeable patient characteristics
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(e.g., age), their personality and behavioral profiles, treatment characteristics and context, and patient
physical health status and life context, to name some examples [3]. While acknowledging the previous,
an increased number of studies have pointed to methodological deficits, namely, in how patients are
monitored during treatments, as key factors influencing current treatment effectiveness [4,5].
Specifically, it has been proposed that a paradigm shift in the practice of psychotherapy towards
an ecological momentary assessment (EMA) is necessary in order to monitor patients repeatedly and
frequently in their natural environment [6,7]. However, simply monitoring the patient does not appear
to be enough to improve the patient’s outcomes [8,9]. In this sense, therapist (and patient) feedback has
been argued to be a fundamental aspect if patient monitoring during therapy is to be effective [1,10].
The aforementioned procedure is known by different terms in the literature, such as routine
outcome monitoring, with outcome or continuous feedback; progress monitoring; or, probably the
most popular, measurement-based care (MBC) [9,11]. For simplicity and readability, the latter will be
preferred throughout this text.
MBC is defined as a periodic and recurrent assessment of the patient’s status over the course of
an intervention using standardized measures. Importantly, the evaluation is followed by immediate,
frequent, and systematic feedback of the patient’s information to the therapist [12,13]. This procedure
has been argued to help therapists to assess actual patient progress, suggest necessary adjustments to the
treatment, and identify patient deterioration or improvement trajectories, thus enhancing the patient’s
response to the intervention [1,14–16]. According to the American Psychological Association’s (APA)
Division 28 Task Force on Empirically Supported Relationships, MBC may also lead to an improvement
in the therapeutic alliance and may avoid premature treatment termination, because MBC encourages
collaboration between patients and therapists, thus promoting engagement, dialogue and discussion
of real-life, daily patient difficulties during sessions. Furthermore, giving feedback to patients raises
awareness of their progress and makes them become more mindful of their symptoms, which may also
enhance the quality of psychological interventions and the patient–therapist alliance [14].
Several studies have shown the efficacy of this systematic patient monitoring with progress
feedback to the therapist in psychological interventions [10,17]. Research also indicates that feedback
from outcome measures enhances treatment effectiveness, particularly in not-on-track patients
(i.e., those who do not make the expected changes) or when it is provided both to clinicians and
patients [8,10,13,14,17,18]. Specifically, providing the therapists with immediate feedback about the
patient’s symptoms appears to reduce the number of early dropouts and improve several treatment
outcomes (depressive and anxiety symptoms, psychosocial functioning, psychosis, quality of life,
therapeutic alliance, etc.) when compared against usual treatment [17,19]. Overall, medium effect sizes
have been reported when using MBC [1,14].
What the existent literature suggests is that MBC is a promising methodology to enhance the
effectiveness of psychological treatments. However, there are a number of flaws into the literature on
MBC that might have limited the impact and dissemination of this procedure [20,21]. Traditionally,
MBC has been conducted with self-report, paper-and-pencil questionnaires that patients complete
before or after therapy sessions. Additionally, assessments are mostly retrospective and based on the
patient’s recalled experiences during the past week [11]. With this information, the therapist examines
and discusses the results during the actual therapy session [22]. As noted earlier, while this practice has
been shown to provide some relevant information, relying on paper-and-pencil retrospective reports
only, where daily experiences are not reported, might result in recall bias, thus making it difficult to
understand patient fluctuations over time [23,24]. Furthermore, focusing on self-reports exclusively is
problematic, as more objective data (e.g., actual number of steps taken or time spent out of the home)
is ignored or based on patient appraisal only.
Currently, the rapid growth of new technologies in our society has changed the way psychotherapy
is conducted. For example, information and communication technologies (ICT) have been argued to
allow therapists to evaluate and receive patient progress feedback in real time, thus minimizing patient
recall bias [25]. Additionally, the use of ICT allows obtaining objective data of patient changes in
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natural settings, for example, using sensors (accelerometers, positioning system, or pedometers, among
others) [22]. Therefore, the use of handheld ICT devices such as smartphones, tablets, or laptops might
increase the effectiveness of MBC by facilitating EMA before, during, and after treatment, providing
the information immediately to therapists and researchers, and making it easier to combine collection
of objective and subjective patient data [11,21,25].
In order to investigate to what extent ICTs are being implemented to enhance psychological
interventions and how their application is effectively improving outcomes, we have conducted a
systematic review to explore how ICT is being used for MBC in face-to-face psychological treatments.
In doing so, we have investigated: 1. what the different technologies and procedures used for MBC
during psychological interventions are and 2. to what extent the use of ICT for MBC is feasible,
acceptable, and effective.
2. Materials and Methods
2.1. Search Strategy
The search was conducted in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses [26]. The search was conducted in February 2020 and included published
and unpublished studies from the electronic databases PubMed, PsycINFO, and SCOPUS. In addition,
reference mining was performed by searching through bibliographies of relevant articles. The selection
of these databases was motivated by previous research showing that PsycINFO has high sensitivity
and specificity when retrieving intervention studies and is especially suitable for psychology research,
and that SCOPUS offers about 20% more coverage than other important databases such as Web of
Science. Additionally, it has been argued that Google Scholar provides inaccurate results, and PubMed
is one of the preferred tools for biomedical research [27,28].
The search strategy included variations of the terms “psychological treatment”, “progress
monitoring”, and “technology” (See Appendix A for the complete list of search terms and combinations).
Due to the diversity of terms, a broad search strategy of terms was used. Synonyms, abbreviations,
and spelling variations were identified for the three concepts and combined in the search using the
“OR” Boolean operator, with non-synonymous concepts combined using “AND”. These terms were
searched in titles and abstracts. The references of included studies and relevant systematic reviews were
searched to identify studies that were missed during the literature search. There were no restrictions
regarding language or publication period, but the search was only conducted in English.
2.2. Inclusion Criteria
Included studies were psychological treatments enhanced by MBC using technology systems.
Specifically, included studies 1. were clinical trials (either feasibility, case studies, and both randomized
or non-randomized investigations); 2. included the use of technology during MBC (both for monitoring
and feedback provision) while undergoing a face-to-face psychological intervention; and 3. involved
feedback to the therapist or to both therapists and patients based on standardized measures.
To be considered MBC, the intervention must satisfy the following components: 1. routine
assessment of a symptom, an outcome, or a process measure; 2. therapist review of data; and 3. therapist
use of data to inform clinical decisions. Therefore, the study population can include patients with any
mental disorder from all ages who are routinely monitored via validated outcome measures using
technologies over the course of a face-to-face psychological treatment.
2.3. Exclusion Criteria
Studies in which technology systems were not used in the whole MBC process, including
the assessment and feedback parts, or where only patients but not therapists were provided with
feedback, were excluded. In addition, studies were excluded if they did not include a face-to-face
psychological intervention.
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2.4. Search and Screening
Initially, 193 publications were identified from database searches and screening of reference lists
(see Figure 1 for the study diagram flow). After excluding duplicates (n = 63), 130 publications were
retained for screening. After initial screening of titles and abstracts, 84 of these documents were
excluded due to eligibility reasons. For the remaining 46 publications, full texts were retrieved. After
eligibility assessment of the full texts, 28 publications were excluded. The majority of publications were
excluded because they did not meet the eligibility criteria, resulting in a final sample that comprised
18 publications.
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Figure 1. Flow diagram of study selection following PRISMA guidelines [26].
The search, screening process, and data extraction were conducted independently by the first two
authors (PGM a d VMB). When in doubt, study eligibility was discussed with a third author (CSR).
After the phase of study eligibility assessment, inter-rater agreement was calculated (Cohen’s kappa).
This coefficient showed a substantial overall agreement, represented by a kappa of 0.908 (SD = 0.064;
95% CI, 0.781, 1.000).
2.5. Data Extraction
The following data were extracted from each included study, using a standardized data-extraction
form developed a priori: authors, study setting (geographical setting and type of clinic), sample
size, study design, study participants (demographics and type of mental disorder), type of
psychological intervention, assessment characteristics (frequency and setting), primary outcomes,
feedback characteristics (to whom, frequency, and setting), type of technology used, technology
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feasibility, and clinical effectiveness. Data was extracted from all full texts by the first author (PGM)
and then discussed with another author (VMB) before it was reviewed by all co-authors.
2.6. Risk of Bias Assessment
All studies included in this review were independently rated for quality by two reviewers
(PGM and VMB). If the rating differed, reviewers discussed the articles to reach consensus with a
third reviewer (CSR). The Study Quality Assessment Tools from the National Heart Lung and Blood
Institute [29] were used to assess study quality and risk of bias. This tool was preferred because
it includes six types of studies and specific criteria according to the study design (i.e., controlled
intervention studies; systematic reviews and meta-analyses; observational cohort and cross-sectional
studies; case-control studies; before–after studies with no control group; and case series studies). This
tool allows reviewers to rate studies as “good”, “fair”, or “poor”. Total quality scores ranged from 9 to
14 points depending on the study design.
2.7. Synthesis of Results
Frequency tables were used to summarize the characteristics of individual studies. We conducted
a systematic review and not a meta-analysis, because the emphasis was not on effect sizes, but on how
MBC with technology was being conducted. Additionally, we anticipated that included studies would
be very heterogeneous, because the review includes any form of psychological intervention, all types
of technologies, several trial designs, and different types of mental disorders and outcomes. Thus,
we performed a narrative synthesis only.
2.8. Additional Analyses
Factors affecting study heterogeneity included variations in the type of mental disorder (e.g., major
depressive disorder or anxiety disorders), outcomes included, treatment characteristics (type, format,
and duration), measures used (clinician-rated versus self-rated), study design, and differences in
the means by which MBC was delivered. The description of the findings was sensitive about the
aforementioned subgroups when possible.
3. Results
3.1. Characteristics of Included Studies
The characteristics of included studies are shown in Table 1. Of the 18 studies included in
the systematic review, eight were published in the USA [30–37], with the remaining studies being
published in Australia (n = 3 [38–40]), the United Kingdom (n = 3 [41–43]), Austria (n = 2 [44,45]),
Greece (n = 1 [46]), and the Netherlands (n = 1 [47]). Most studies took place in outpatient settings
(n = 15, 83.33%) such as mental health services (n = 3 [33,34,47]), specialist clinics (n = 4 [36,38,39,43]),
hospital clinics (n = 7 [31,35,37,41,42,45,46]), and university clinics (n = 1 [32]); only three of them
were conducted in inpatient settings [30,40,44]. In terms of design, six studies were feasibility pilot
investigations (single group) [30,31,34,36,37,44]; four studies were case studies [32,39,45,46]; four
studies were randomized controlled trials (RCTs) [35,38,42,47]; two of them were non-randomized
controlled trials [33,40]; and two were pre–post investigations [41,43]. The sample sizes of the included
investigations ranged from 1 to 2233 participants.
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Table 1. Characteristics of the included studies.
Reference Country Setting PsychologicalDisorder Sample size Study Design
Type of Psychological
Intervention
[30] California (USA) Specialist inpatienttreatment center PTSD 27 Tx SG (feasibility study)
Residential group psychotherapy
(4–5 months)
[31] Pittsburgh (USA) Outpatient PsychiatricInstitute and Clinic
Anxiety disorders
(children from 9 to
14 years old)




SG (feasibility pilot trial)




Outpatient clinic at the
Family Institute at
Northwestern University
Couple problems 1 Tx Case study Four Couple MultisystemicPsychotherapy sessions
[33] California University:Berkeley (USA)
Outpatient behavioural
health clinic Depression 85 (40 cont. + 45 Tx) nRCT (not blinded)
16 weeks of weekly group CBT
therapy
[34] California (USA) 4 Outpatient EarlyPsychosis clinics Psychotic disorder 61 Tx SG (feasibility study)
Early Psychosis Program
(up to 5 months)
[35] New York (USA) Outpatient primary care Substance use 240 (83 cont. + 77 Tx +80 Tx HealthCall)
Three-arm RCT (1:1:1
allocation ratio)










76 Tx SG (feasibility pilot trial) Early Psychosis Program(minimum 3 months)
[37] WashingtonUniversity (USA)
Outpatient primary care










Voices Clinic and clinical
services
Schizophrenia 34 (17 cont. + 17 Tx)
A single-blind, parallel
group, pilot RCT (1:1
allocation ratio)
Brief CBT (four in-person
therapy sessions) + EMA + EMI
[39] Melbourne(Australia)
Outpatient Specialist
Voices clinic Schizophrenia 1 Tx Case study
Brief CBT (four in-person





Mood and Anxiety 1308 (408 Tx Fb +, 439nFb + 461 cont.) nRCT 10 days of intensive CBT group
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Table 1. Cont.
Reference Country Setting Psychological Disorder Sample size Study Design Type of PsychologicalIntervention




CBT or High-intensity CBT,
interpersonal psychotherapy and
counselling




CBT or High-intensity CBT,
interpersonal psychotherapy and
counselling














151 Tx SG (feasibility pilot trial)
Psychotherapy (8 weeks in the
day-treatment clinic and
12 weeks in the inpatient clinic)
[45] Salzburg (Austria) Outpatient clinic Bulimia nervosa 1 Tx Case study six Rogerian person-centredpsychotherapy sessions
[46] Thessaloniki(Greece)
Alzheimer day care














475 (159 Tx FbT; 172
Tx FbTP; 144 cont.
nFb)
RCT
Long and short psychotherapy
(CBT, client-centered,
psychodynamics)
Note: Cont., control group; Tx, treatment group; nRCT, non-randomized controlled trial; CBT, Cognitive-Behavioural Therapy; RCT, randomized controlled trial; EMA, ecological
momentary assessment; EMI, ecological momentary intervention; FbT, feedback to the therapist; FbTP, feedback to the therapist and the patient; Fb, feedback; nFb, no-feedback; FIMM,
Facilitated Integrated Mood Management; SG, single group design.
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The included studies targeted very heterogeneous diagnoses. However, depression and anxiety
disorders were the most frequent (n = 6, 33.33% of studies [31,33,37,40–42]). The remaining disorders
were schizophrenia spectrum disorders (n = 4, 22.22% of studies [34,36,38,39]), bulimia nervosa (n = 1,
5.6% of studies [45]), substance use (n = 1, 5.6% of studies [35]), dementia (n = 1, 5.6% of studies [46]),
post-traumatic stress (n = 1, 5.6% of studies [30]), bipolar disorder (n = 1, 5.6% of studies [43]), couple
problems (n = 1, 5.6% of studies [32]), and combinations of heterogeneous disorders together (n = 2,
11.11% of studies [44,47]). The majority of treatments were addressed to adult populations (n = 16) and
only two investigations (n = 2 [34,36]) aimed at treating mental health problems in younger populations
(i.e., adolescents and young adults).
Regarding the treatments offered in the included studies, different face-to-face interventions
were provided across studies. However, cognitive behavioral therapy (CBT) was the most frequent
(n = 13). Other therapeutic options were client-centered psychotherapy (n = 1 [45]), collaborative
care (n = 1 [37]), an early psychosis program (n = 2 [34,36]), and couple multisystemic psychotherapy
(n = 1 [32]). The format of the intervention was mainly individual (n = 15), but some studies included
group treatments (n = 3 [30,33,40]). Finally, the intensity (i.e., frequency) of the intervention also
differed across investigations. Some studies implemented a low-intensity treatment plan (i.e., less
than eight sessions; n = 6 [32,35,38,39,43,45]), while others applied a higher-intensity intervention
(i.e., more than eight sessions; n = [30,33,34,36,37,40,44,46]) or both a low- and a high-intensity treatment
(n = 4 [31,41,42,47]).
3.2. MBC Characteristics
3.2.1. Assessment Procedure Used to Track the Patient’s Status
The characteristics of studies included in the review are described in Table 2. Most studies
(n = 9 [30,31,33,35,38–40,44,46]) monitored their patients daily. The remaining studies monitored
their patients weekly (n = 4 [32,41,42,47]), before every therapy session, or both daily and weekly
(n = 5 [34,36,37,43,45]). In the latter studies conducting assessments both daily and weekly, daily
assessments usually included shorter questionnaires that evaluated therapeutic process outcomes,
mood, or medication adherence, while longer outcome scales (i.e., measures of depressive or anxiety
symptoms) were administered weekly. Treatment effectiveness was assessed most commonly with
the primary outcome measures of interest for the investigation, which most often were the Patient
Health Questionnaire-9 for depressive symptoms and the Generalised Anxiety Disorder-7 for anxiety
symptoms (n = 4 [33,37,41,42]). Other outcomes included the frequency and amount of drug use
(n = 1 [35]); the Subjective Experiences of Psychosis Scale, the Auditory Hallucinations subscale of
the Psychotic Symptom Rating Scales for psychotic symptoms, and the Depression Anxiety Stress
Scale for negative emotional symptoms (n = 2 [38,39]); the Outcome Questionnaire-45 (n= 1 [47]);
the Therapy Process Questionnaire (n = 1 [44]); the World Health Organization’s Wellbeing Index
(n = 1 [40]) for well-being; the Symptom Checklist-90 for bulimia symptoms and the Intersession
Experience Questionnaire for the psychotherapy process (n = 1 [45]); the Altman Self-Rating Mania
scale and the 16-item Quick Inventory of Depressive Symptoms-Self Report scale (n = 1 [43]); and other
clinical measures related to sleep, mood, medication use, or daily functioning (n = 6 [30–32,34,36,46]).
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Table 2. Measurement-based care characteristics.
Reference Assessment Frequency and Setting Primary Outcome Measures Feedback to Feedback Frequency and Setting Type of Technology Used






P: T regularly shared P progress in order to incorporate
strategies in therapy sessions and treatment plan.T: They got
patient information several times a week in a graph format to
discuss with them during sessions, to encourage them and
monitor them.
EMA and Text messages
[31]
Daily questions about recent
emotional events (e.g., emotions,
scenario, somatic symptoms,
automatic thoughts) + answers on
demand by the participant
Skills entries and satisfaction
with the treatment. P and T
P: They received personalized feedback from therapists.T:
Information and graphs from the portal about patients’






[32] Online before every session STIC: set of questionnaires T and cliniciansstakeholders
T: On-demand graphs of patient progress were provided to the
therapist through STIC STIC online
[33]
Once daily mood monitoring
messages at random between 8 a.m.
and 8 p.m.
Attendance to therapy, duration
of therapy and PHQ-9 P and T
P: They received feedback about their mood responsesT: T
reviewed information from an online dashboard were patient
progress is shown. T can periodically review the graphs,





[34] Daily and weekly surveys (between5 p.m. and 10:30 p.m.)
Mood, medication use,
socialization and conflict P and T
P: They discussed their feedback with the T at every session.T:
They reviewed and discussed patient information (plots of
symptoms over time, etc.) on the dashboard with P during
sessions and between sessions.
Smartphone app: RealLife
Exp + web-based platform
[35] Once daily call (HealthCall) for self-monitoring
Primary drug use (frequency




P: They received the feedback at 30 and 60 days, where their
information was discussed with the T.T: At 30 and 60 days, T
discussed with P the generated graphs based on HealthCall
about their drug use, moods and health behaviors.
Phone IVR system
[36]
Daily surveys (at 5 p.m. until 11:55
p.m.), weekly surveys (Sundays at 10
a.m. until Monday 11:55) and
monthly in-person psychosocial
assessments with research staff







T: They received alerts from the dashboard when P scores were





[37] 3/4 times daily, weekly; 8/12 weeks PHQ-9 and GAD-7 P and T
P: P received notifications about their progress in the app,
becoming more aware of their symptoms.T: T reviewed
patient-reported information via an online dashboard and
visualized patient progress graphs.
Smartphone app + online
platform
[38]
Session 1 and 2: 10 daily evening
EMA for 6 days. Session 3 and 4: 8
evening daily EMA (monitor changes
in voices and coping strategies)
SEPS, PSYRATS-AH, and
DASS-21 P and T
P: In session 2, P received a summary sheet with their EMA
progress.T: In session 2, EMA feedback was discussed with the
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Table 2. Cont.
Reference Assessment Frequency and Setting Primary Outcome Measures Feedback to Feedback Frequency and Setting Type of Technology Used
[39]
Session 1 and 2: 10 daily evening
EMA for 6 days. Session 3 and 4: 8
evening daily EMA (monitor changes
in voices and coping strategies)
SEPS, PSYRATS-AH, and
DASS-21 P and T
P: In session 2, P received a summary sheet with their EMA
progress.T: In session 2, EMA feedback was discussed with the P in
order to guarantee understanding, detect predictors and avoid
causation.
Smartphone app: RealLife
Exp + web-based platform
[40] Daily self-reported measures ofwell-being Well-being (WHO-5) P and T
P: They received routinely individualized information about their
progress in group discussion with the therapist.T: T received daily
automatic plots of each patient’s outcomes within trajectories.
Touch-screen technology
in therapy rooms
[41] Weekly (session-by-session) PHQ-9 and GAD-7 P and T
P: They received their feedback in session with the therapist, where
the information was reviewed, discussed and used to guide the
treatment plan.T: They had access to patient progress graphs and
response curves from the monitoring system, and they were
warned automatically when a P was not-on-track.
Computer PCMIS
[42] Weekly (session-by-session) PHQ-9 and GAD-7 P and T
P: They received their feedback in session with the therapist, where
the information was reviewed, discussed and used to guide the
treatment plan.T: They had access to patient progress graphs and
response curves from the monitoring system, and they were
warned automatically when a P was not-on-track.
Computer PCMIS
[43]
Twice a day (only during
psychoeducation sessions) and once
a week
Daily: mood and sleepWeekly:




P: P received their feedback at every session with the T.T: T
reviewed patient progress from daily mood rating and weekly
scales from the previous week and discussed with the P the
relationship between his/her mood changes and stressors.
Phone text messages or
e-mails (True Colours
mood monitoring system)
[44] Daily process monitoring(during evenings). TPQ T
T: On demand. Feedback was used for individualizing therapeutic
decisions. SNS
[45]
Daily measures of psychotherapy
process. Weekly measure of therapy
outcome.
IEQ daily, weekly SCL-90
(Bulimia) P, T and researchers
P: They viewed their progress and estimated their moods and
symptoms during the past day.T: They had access to P data from
the system in order to adapt the intervention delivered.
Smartphone: DynAMo
web app
[46] Daily monitoring Sleep patterns, physical activity,and activities of daily living P, T and caregivers
P and caregiver: They could see a proportionate share of the
information adapted to their needs.T: Information collected was





[47] Once a week just before therapysession (at waiting room) OQ-45 P and T, or only T
P: P can access the feedback via email or into their portal system.T:
T could access the feedback via email or in their portal system and
could discuss the feedback information (progress charts and a
message) with the P based on the OQ-45 patient’s scores.
Computer: Web-based
monitoring app
Note: PHQ-9, Patient Health Questionnaire-9; P, patient; T, therapist; GAD-7, Generalised Anxiety Disorder-7; EMA, Ecological Momentary Assessment; SEPS, Subjective Experiences of
Psychosis Scale; PSYRATS-AH, Auditory Hallucinations subscale of the Psychotic Symptom Rating Scales; DASS-21, Depression Anxiety Stress Scale; OQ-45, Outcome Questionnaire; IEQ,
Intersession Experience Questionnaire; SCL-90, Symptom Checklist-90; QIDS, Quick Inventory of Depressive Symptomatology; ASRM, Altman Self Rating Mania Scale; WHO-5, World
Health Organization’s Wellbeing Index; STIC, Systemic Therapy Inventory of Change System; CBT, Cognitive Behavioral Therapy; TPQ, Therapy Process Questionnaire; IVR, interactive
voice response; App, mobile application; STIC, Systemic Therapy Inventory of Change System; SNS, Synergetic Navigation System; PCMIS, Patient Case Management Information System.
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3.2.2. Feedback Procedure
The majority of studies provided feedback to both therapists and patients (n = 15). The remaining
studies gave feedback to therapists only (n = 3 [32,36,44]). Most studies used feedback to track the
patients’ progress focusing on key aspects during treatment and to monitor responses in-between
sessions. Even when the feedback was not directly provided to the patient, this information was used
to discuss patient progress during treatment sessions or to take clinical decisions (e.g., emphasize a
specific content during session).
Feedback included information about treatment evolution in progress charts, summary sheets,
graphs of scores and curves, and plots of scores within trajectories. Feedback information was either
sent periodically to the therapist in response to patient assessments or on-demand (weekly or daily).
In some studies, feedback to the therapist appeared when the patients’ responses were considered
clinically significant according to pre-established criteria.
3.3. Technology Characteristics
The technology characteristics of included studies are presented in Table 2. Most studies included
handheld technology, such as smartphone apps (n = 7 [31,34,36–39,45]), touch-screen technologies
(n = 2 [40,46]), or laptops (n = 5 [32,41,42,44,47]), together with a web-based platform for the therapist.
The remaining studies used phone text messages (n = 2 [30,33]), e-mail (n = 1 [43]), or a phone
interactive voice response system (n = 1 [35]). For example, in one study, automated text messages and
a web-based platform (e.g., HealthySMS) were used [33]. In other investigations, authors implemented
an Internet-based system, such as the Patient Case Management Information System (PCMIS), or an
electronic clinical record system which includes outcome-monitoring graphs that chart depression
and anxiety scores at every session [41,42]. A similar example was the Synergetic Navigation System,
an Internet-based device for data collection (with web-compatible devices such as PCs, tablets, or
smartphones) and data analysis that allows for the implementation of questionnaires at any chosen
interval [44]. Another Internet-based system was the DynAMo web app, a piece of software that
combines algorithm-based treatment planning, process monitoring, and outcome monitoring, which
can be used by both researchers and clinicians to plan treatments and monitor psychotherapeutic
processes [45]. One investigation used the Systemic Therapy Inventory of Change System, an online system
that assesses and tracks changes in the patients’ interpersonal system, as well as in the therapeutic alliance,
and also feeds these data back to the therapists on demand [32]. A final example of an Internet-based
system used in one of the included investigations was Ginger.io, an mHealth software program comprising
a therapist dashboard and an app which can collect data from self-report surveys sent to the participant in
addition to “passive” data from the participant’s phone, such as number of calls and SMS messages, and
movement patterns based on Global Positioning System data [36].
3.3.1. Technology Feasibility
Because of the large differences in sample sizes across investigations (Table 3), case studies
with one to four participants [32,39,45,46] have been described in previous sections but will not be
considered in the feasibility and effectiveness summaries. The remaining studies included at least
17 participants, and therefore will be discussed in detail here and in Table 3. Overall, the results
demonstrated that enhancing MBC in psychological therapy with technology was generally feasible
and acceptable (Table 3). This statement is supported by the high average response rate for daily
(mean = 63.3%, range = 40%–81% [34,36,43]), weekly (mean = 73.0%, range = 39%–88% [34,36,37,43]),
and monthly (92.7% [30]) symptom monitoring across studies, low average missing data rates amongst
patients (13% [44]), and high completion rates (mean = 77.8%; range = 64.1%–90% [31,35,38,40,44]).
In addition, several studies reported satisfaction with the technology used to improve MBC in the
intervention delivered, and most of them revealed that patients and therapists would recommend the
technology used as part of the treatment [31,34,38].
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Table 3. Usability, acceptability, and effectiveness of technology-supported measurement-based care.
Reference Sample Size Feasibility of Technology Clinical Effectiveness
[30] 27 Tx Monthly: 92.7% NA
[31] 9 Tx
Completion rate was 82.8%. Patients reported the app being easy
to use. All parents report treatment satisfaction and would
recommend the program.
NA
[33] 85 (40 cont. + 45 Tx) NA
Technology-supported MBC significantly increased treatment adherence (median
of 13.5 weeks before dropping out) compared to traditional CBT (median of 3
weeks before dropping out).
Effect sizes of technology-supported MBC CBT on depressive symptoms’ severity
(z = −5.80) were larger than for traditional CBT (z = −3.12), but differences were
not significant
[34] 61 Tx
Moderate survey completion (daily = 40%; weekly = 39%). In
general, both T (66%) and P (85%) reported they would continue
using the app as part of the treatment.
NA
[35] 240 (83 cont. + 77 Tx + 80 Tx) HealthCall shows a great retention rate and response rate (64.1%),supporting feasibility, patient acceptability and generalizability.
At 12-month follow-up, reductions in non-injection drug use were comparable in
traditional and technology-supported MBC motivational interviewing and
superior than in the control condition. In the subset of patients with drug
dependence, drug use was significantly lower in the technology-supported MBC
condition at 12 months post-treatment. At 60 days, treatment retention in the
technology-supported MBC group (88.8%) was superior than in the motivational
intervention only condition (81.8%) and the control condition (78.3%)
[36] 76 Tx
Feasibility and acceptability of the smartphone app as an adjunct
treatment tool is supported by the high response rate sate (weekly
surveys: 77%; daily surveys: 69%)
NA
[37] 17 Tx The feasibility and acceptability of the mobile platform issupported by the high early response rate (weekly = 88%). NA
[38] 34 (17 cont. + 17 Tx)
High completion rates (74%) of EMA questionnaires and good
satisfaction of participants support the feasibility and acceptability
of the study, respectively.
Compared with the usual treatment, the technology-supported MBC treatment
resulted in large improvements in confidence in coping with voices (Hedges g =
1.45) and medium improvements in understanding of voices (Hedges g = 0.61)
and in psychotic symptoms (Hedges g = 0.51). Both groups showed similar
changes in the impact of psychosis.
[40] 1308 (408 Tx Fb +, 439 nFb +461 cont.) High rates of touch-screen questionnaire completion (over 90%).
Technology-supported MBC for NOT patients was more effective than traditional
CBT or monitoring without feedback in reducing depressive symptoms and the
impact of emotions on functioning, as well as on increasing vitality. By contrast,
changes in well-being, anxiety, and stress were comparable across conditions.
[41] 594 (349 cont. + 245 Tx) MBC technology was generally acceptable and feasible to integratein routine practice.
Technology-supported MBC achieved comparable reductions in depression and
anxiety compared to controls, but with significantly less time (adjusted mean =
10.25, SE = 0.45 vs. adjusted mean = 6.59, SE = 0.51) and cost (between £65.88 and
£129.20 cost reductions per treatment). Cases in the control condition were twice
as likely to become not-on-track patients compared to those in the
technology-supported MBC.
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Table 3. Cont.
Reference Sample Size Feasibility of Technology Clinical Effectiveness
[42] 2233 (1057 cont. + 1176 Tx) NA
NOT patients in the technology-enhanced MBC condition obtained significantly
larger reductions in depressive (d = 0.23) and anxiety symptom severity (d = 0.19),
as well as improved work and social adjustment (d = 0.19) compared with active
controls (traditional CBT).
[43] 19 Tx High response rate (daily = 81%, weekly = 88%) NA
[44] 151 Tx
High average compliance rates (78.3%) and low average missing
data rates (13%) amongst the inpatients support the feasibility. NA
[47] 475 (159 Tx FbT; 172 Tx FbTP;
144 cont. nFb)
NA
In short-term interventions (less than 35 weeks), receiving feedback was
protective of negative outcomes in NOT cases (d = 1.28). No significant differences
between conditions were found for on-track patients, but there was a trend for the
technology-supported MBC group to be more effective (d = 0.24 at 35 weeks and
d = 0.29 at 78 weeks) and to have lower deterioration rates (z = 1.3), especially
when feedback was provided to both patient and therapist.
Note: Cont., Control Group; Tx, Treatment Group; FbT, Feedback to The Therapist; FbTP, Feedback to The Therapist and The Patient; Fb, Feedback; nFb, No Feedback; NA, Not
Applicable/Not Specified; IVR, Interactive Voice Response; App, Mobile Application; EMA, Ecological Momentary Assessment; MBC, Measurement-Based Care; NOT, Not-on-Track
patients; T, Therapist; P, Patient. The feasibility and effectiveness reports are not provided for case studies due to the reduced number of patients (n ≤ 4).
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3.3.2. Clinical Effectiveness
As summarized in Table 3, data about clinical effectiveness was described in seven
studies, including four RCTs [35,38,42,47], two nRCTs [33,40], and a quasi-experimental pre–post
investigation [41]. All RCTs included active controls (i.e., traditional face-to-face psychological
treatment) without MBC. According to these investigations, the use of technology-supported MBC
appears to significantly reduce symptom severity, and changes are sometimes larger than with
traditional interventions [38], especially in patients at risk of poor response to treatment (i.e., not-on-track
cases) [35,40,42,47], which is consistent with previous research [42,46]. Furthermore, one study showed
that although traditional CBT and technology-enhanced MBC CBT were comparable in terms of
treatment effectiveness, the latter significantly reduced therapy duration and cost of treatment [41].
Also in favor of technology-assisted MBC, another investigation revealed that patients stayed in
therapy longer (i.e., higher adherence) in the experimental condition, that is, when MBC was supported
by technology (group CBT with a text messaging adjunct) as opposed to traditional MBC without
technology (group CBT without the text messaging adjunct) [33]. In sum, most studies suggest
that technology-supported MBC has the potential to improve the efficacy and cost-effectiveness of
psychotherapy, especially for not-on-track individuals.
3.4. Risk of Bias Assessment
As observed in Tables 4–7, studies included in this review could be placed in four of the categories
proposed by the National Heart Lung and Blood Institute [29], namely, case studies, before-after
studies; observational cohort and cross-sectional studies; and controlled intervention studies. Overall,
the four studies classified as case studies had a “good” quality, with total scores ranging from 5 to
7 points out of a maximum of 9 points [32,39,45,46]. Even so, none of them had follow-up sessions, or
these were not reported, and two studies did not include a complete case definition [32,45]. Secondly,
the two before–after studies could also be rated as “good” quality investigations, as both obtained
9 points of a maximum of 12 [41,43]. The main issue with one of the studies was related to sample size,
although this concern was justified, as this was a pilot study and authors reported the previous in the
limitation section [43]. The six studies classified as observational, cohort and cross-sectional studies
correspond to feasibility and acceptability studies, and some quality criteria, such as numbers 7, 8, 12,
and 14, were not applicable [30,31,34,36,37,44]. Overall, feasibility and acceptability studies did not
meet most criteria required in observational and cross-sectional studies (they met only seven or eight
criteria of a maximum of 14), so their quality could only be rated as “fair”. It is important to note that
just two studies maintained 80% of the sample [30,31] and four studies did not meet the participation
rate of 50% from eligible participant criteria [30,31,37,44]. Finally, two of the controlled intervention
studies [33,40] were rated as “poor” quality as they were non-randomized and did not follow most
of the criteria for controlled studies (i.e., randomization, blind allocation, or assessment). These two
studies met, respectively, only two [40] and eight [33] criteria of a maximum of 14. The remaining four
controlled intervention studies [35,38,42,47] were “good” quality investigations despite the lack of
blinded allocation and assessment [35,42,47] and relatively high drop-out rates [42,47].
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Table 4. Quality assessment of case studies.
[32] [39] [45] [46]
1. Was the study question or objective clearly stated? Yes Yes Yes Yes
2. Was the study population clearly and fully described,
including a case definition? No Yes No Yes
3. Were the cases consecutive? NA NA NA No
4. Were the subjects comparable? NA NA No Yes
5. Was the intervention clearly described? Yes Yes Yes Yes
6. Were the outcome measures clearly defined, valid, reliable,
and implemented consistently across all study participants? Yes Yes Yes Yes
7. Was the length of follow-up adequate? NR No No NR
8. Were the statistical methods well-described? Yes Yes Yes Yes
9. Were the results well-described? Yes Yes Yes Yes
Total score (maximum 9 points) 5 6 5 7
Note: CD, Cannot Determine; NA, Not Applicable; NR, Not Reported.
Table 5. Quality assessment of before–after studies.
[41] [43]
1. Was the study question or objective clearly stated? Yes Yes
2. Were eligibility/selection criteria for the study population prespecified and
clearly described? Yes Yes
3. Were the participants in the study representative of those who would be eligible
for the test/service/intervention in the general or clinical population of interest? NR Yes
4. Were all eligible participants that met the prespecified entry criteria enrolled? NR No
5. Was the sample size sufficiently large to provide confidence in the findings? Yes No
6. Was the test/service/intervention clearly described and delivered consistently
across the study population? Yes Yes
7. Were the outcome measures prespecified, clearly defined, valid, reliable, and
assessed consistently across all study participants? Yes Yes
8. Were the people assessing the outcomes blinded to the participants’
exposures/interventions? No NA
9. Was the loss to follow-up after baseline 20% or less? Were those lost to follow-up
accounted for in the analysis? Yes/Yes Yes/Yes
10. Did the statistical methods examine changes in outcome measures from before
to after the intervention? Were statistical tests done that provided p values for the
pre-to-post changes?
Yes Yes
11. Were outcome measures of interest taken multiple times before the intervention
and multiple times after the intervention (i.e., did they use an interrupted
time-series design)?
Yes Yes
12. If the intervention was conducted at a group level (e.g., a whole hospital, a
community, etc.) did the statistical analysis take into account the use of
individual-level data to determine effects at the group level?
Yes Yes
Total score (maximum 12 points) 9 9
Note: CD, Cannot Determine; NA, Not Applicable; NR, Not Reported.
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Table 6. Quality assessment of observational cohort and cross-sectional studies.
[30] [31] [34] [36] [37] [44]
1. Was the research question or objective in this paper
clearly stated? Yes Yes Yes Yes Yes Yes
2. Was the study population clearly specified
and defined? Yes Yes Yes Yes Yes Yes
3. Was the participation rate of eligible persons at
least 50%? NR NR Yes Yes No NR
4. Were all the subjects selected or recruited from the
same or similar populations? Were inclusion and
exclusion criteria for being in the study prespecified and
applied uniformly to all participants?
Yes Yes Yes Yes Yes Yes
5. Was a sample size justification, power description, or
variance and effect estimates provided? NR NR NR NR NR NR
6. For the analyses in this paper, were the exposure(s) of
interest measured prior to the outcome(s)
being measured?
Yes Yes Yes NA Yes Yes
7. Was the timeframe sufficient so that one could
reasonably expect to see an association between exposure
and outcome if it existed?
NA NA NA NA NA NA
8. For exposures that can vary in amount or level, did the
study examine different levels of the exposure as related
to the outcome (e.g., categories of exposure, or exposure
measured as continuous variable)?
NA NA NA NA NA NA
9. Were the exposure measures clearly defined, valid,
reliable, and implemented consistently across all study
participants?
Yes Yes Yes Yes Yes Yes
10. Was the exposure(s) assessed more than once
over time? Yes Yes Yes Yes Yes Yes
11. Were the outcome measures clearly defined, valid,
reliable, and implemented consistently across all study
participants?
Yes Yes Yes Yes Yes Yes
12. Were the outcome assessors blinded to the exposure
status of participants? NA NA NA NA NA NA
13. Was loss to follow-up after baseline 20% or less? Yes Yes No No No No
14. Were key potential confounding variables measured
for their impact on the relationship between exposure(s)
and outcome(s)?
NA NA NA NA NA NA
Total score (maximum 14 points) 8 8 8 7 7 7
Note: CD, Cannot Determine; NA, Not Applicable; NR, Not Reported.
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Table 7. Quality assessment of controlled intervention studies.
[33] [35] [38] [40] [42] [47]
1. Was the study described as randomized, a randomized
trial, a randomized clinical trial, or an RCT? No Yes Yes No Yes Yes
2. Was the method of randomization adequate (i.e., use of
randomly generated assignment)? NA Yes Yes NA Yes Yes
3. Was the treatment allocation concealed (so that
assignments could not be predicted)? NA Yes Yes NA Yes Yes
4. Were study participants and providers blinded to
treatment group assignment? No No No No No No
5. Were the people assessing the outcomes blinded to the
participants’ group assignments? No NA Yes No No NA
6. Were the groups similar at baseline on important
characteristics that could affect outcomes (e.g.,
demographics, risk factors, co-morbid conditions)?
Yes Yes Yes Yes Yes No
7. Was the overall drop-out rate from the study at
endpoint 20% or lower of the number allocated to
treatment?
Yes Yes Yes NR No No
8. Was the differential drop-out rate (between treatment
groups) at endpoint 15 percentage points or lower? Yes Yes Yes NR Yes Yes
9. Was there high adherence to the intervention protocols
for each treatment group? Yes Yes Yes NR Yes Yes
10. Were other interventions avoided or similar in the
groups (e.g., similar background treatments)? Yes NR Yes NR Yes NR
11. Were outcomes assessed using valid and reliable
measures, implemented consistently across all study
participants?
Yes Yes Yes No Yes Yes
12. Did the authors report that the sample size was
sufficiently large to be able to detect a difference in the
main outcome between groups with at least 80% power?
No Yes No NR Yes Yes
13. Were outcomes reported or subgroups analyzed
prespecified (i.e., identified before analyses were
conducted)?
Yes Yes Yes Yes Yes Yes
14. Were all randomized participants analyzed in the
group to which they were originally assigned, i.e., did
they use an intention-to-treat analysis?
Yes No Yes NR Yes Yes
Total score (maximum 14 points) 8 10 12 2 11 9
Note: CD, Cannot Determine; NA, Not Applicable; NR, Not Reported.
4. Discussion
The aim of the present study was to systematically review evidence on how ICT is being
used for MBC in psychological treatments. To the best of our knowledge, this is the first attempt
to systematically examine the different technologies that have been used so far for MBC during
psychological interventions and to explore to what extent the use of ICT for MBC is feasible, acceptable,
and effective.
One important finding was that only 18 studies met our inclusion criteria, which suggests that
this is a field that requires more research. Additionally, the included studies varied greatly in terms of
study design, diagnoses, MBC characteristics, and technology used, which again suggests that more
investigation and replication will be needed to obtain robust findings about different technological
solutions for MBC and to facilitate the generalization of the results to different populations. Future
research should also examine the implication of technology systems for MBC in specific populations
(e.g., children and adolescents, who are more familiar with technology systems). Furthermore, most of
the included studies focused on mood and anxiety disorders, so it would be interesting to investigate
the effects of technology used for MBC in other mental disorders.
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As noted in the results section, the included technologies to support MBC were frequently
handheld ICTs, such as smartphone apps, tablets, or laptops, which were involved both in the patient
monitoring process and in the feedback to the therapists. In this sense, while tablets and laptops might
be more difficult to use for EMA, it is encouraging that smartphone apps, which might facilitate EMA
to a greater extent than other technologies, are also being used as supporting technologies for MBC.
An important finding regarding technology was that, overall, the use of technology for MBC during
psychological interventions appears to be feasible and acceptable. In addition, technology in MBC was
found to be effective [38] and cost-effective [41], particularly for not-on-track patients [35,40,42,47], as
revealed in previous studies using MBC without technology [1]. Importantly, treatment engagement
(i.e., time until dropout) was also enhanced with technology-supported MBC [33]. While these findings
should be interpreted with caution, due to the limited number of existing investigations and the
reduced number of controlled trials comparing technology-supported and non-supported MBC, the
results suggest that the use of ICT to support MBC should continue to be tested in the future.
It is important to acknowledge that technology-supported EMA for MBC is different to a
similar concept, which is ecological momentary intervention (EMI). Specifically, while in EMI a
given intervention is provided in response to EMA in a timely manner (e.g., providing therapeutic
skills with an app based on patient responses), in MBC EMA is only used to enhance face-to-face
psychological interventions.
It is also important to note that some studies were excluded from this systematic review for several
reasons which should be mentioned here. For instance, in some investigations, the monitoring process
was not used to guide therapeutic decisions, even though technology was used for monitoring (thus,
this would not be considered MBC). Conversely, in other studies, the technology was only used in one
part of the MBC process, most frequently during the feedback part, but not for EMA (e.g., assessments
were made in a paper-and-pencil approach, but then the information was introduced in a computer
and presented in graphs or charts to the therapists and/or patients) [16,48–50].
4.1. Limitations
Some limitations should also be considered when interpreting the results of the present systematic
review. As in previous similar reviews [13,18], the heterogeneity of studies with respect to sample
size, measures used, and methodology, to name some examples, made it difficult to piece together
the results and restricted the implementation of a meta-analysis which affects the generalizability
and robustness of findings. Moreover, the majority of included studies were feasibility pilot studies,
case studies, or non-RCTs. Although these designs can yield valuable information, RCTs, which have
been rarer, are considered superior because of their higher internal validity and, therefore, higher
robustness of the evidence indicating a (causal) relationship. Additionally, some factors might have
biased the present systematic review findings, including the fact that only three databases were used
for the search, and the possibility that studies where ICT was not feasible or did not add any value
have not been published. Finally, it is important to note that this systematic review is limited to the
interpretations of the authors who conducted the systematic review.
4.2. Conclusions
To conclude, this systematic review found preliminary support for the use of technology in
MBC during psychological interventions. The use of ICTs in MBC has brought some encouraging
contributions to the evolution of psychotherapy and its inclusion in routine care might significantly
change the way psychotherapists work. Particularly, the provision of real-time information on symptom
progress over the course of psychological interventions might help therapists detect and rapidly react
to problems that might occur during treatment (e.g., exacerbation in symptomatology or low adherence
to recommended practices). This would make current interventions more flexible and personalized [22]
and should favor the psychotherapeutic relationship during face-to-face interventions. Additionally,
this might increase the patients’ awareness of their own progress.
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In addition, technology was generally found to be a feasible and acceptable add-on tool for the
MBC process. Therefore, the use of technology for improving the MBC process is mostly supported, as
it might facilitate EMA and offer some potential for improving psychotherapy thanks to the real-time
connection between patient assessment and therapist and patient feedback [32]. While the presented
results are, overall, encouraging, especially for not-on-track patients, more research is required in this
field, especially RCTs comparing technology-supported MBC with traditional MBC without technology.
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Appendix A. Complete List of Search Terms and Combinations
The first set of search terms were related to psychological treatment: “psychotherapy” OR
“psychological treatment” OR “psychological intervention” OR “CBT” OR “cognitive-behavioral
therapy” OR “cognitive behavioral therapy” OR “cognitive-behavioural therapy” OR “cognitive
behavioural therapy”. The second set of search terms were related to progress monitoring: “outcome
feedback” OR “ecological momentary”, OR “outcome monitoring” OR “enhanced treatment” OR
“enhanced assessment” OR “enhanced monitoring”. The last set of search terms were related to the
use of technology through diverse devices: “mHealth” OR “eHealth” OR “technology” OR “app” OR
“smartphone” OR “phone”. These sets of search terms were linked with the Boolean operator AND.
References
1. Shimokawa, K.; Lambert, M.J.; Smart, D.W. Enhancing treatment outcome of patients at risk of treatment
failure: Meta-analytic and mega-analytic review of a psychotherapy quality assurance system. J. Consult.
Clin. Psychol. 2010, 78, 298–311. [CrossRef] [PubMed]
2. Lambert, M.J.; Hansen, N.B.; Finch, A.E. Patient-focused research: Using patient outcome data to enhance
treatment effects. J. Consult. Clin. Psychol. 2001, 69, 159–172. [CrossRef] [PubMed]
3. Kaplan, S.H.; Billimek, J.; Sorkin, D.H.; Ngo-Metzger, Q.; Greenfield, S. Who can respond to treatment?
Med. Care 2010, 48, S9–S16. [CrossRef] [PubMed]
4. McDevitt-Murphy, M.E.; Luciano, M.T.; Zakarian, R.J. Use of ecological momentary assessment and
intervention in treatment with adults. Focus (Madison) 2018, 16, 370–375. [CrossRef]
5. Suso-Ribera, C.; Mesas, Á.; Medel, J.; Server, A.; Márquez, E.; Castilla, D.; Zaragozá, I.; García-Palacios, A.;
Mesas, A.; Medel, J.; et al. Improving pain treatment with a smartphone app: Study protocol for a randomized
controlled trial. Trials 2018, 19, 145. [CrossRef]
6. Colombo, D.; Fernández-Álvarez, J.; Suso-Ribera, C.; Cipresso, P.; Valev, H.; Leufkens, T.; Sas, C.;
Garcia-Palacios, A.; Riva, G.; Botella, C. The need for change: Understanding emotion regulation antecedents
and consequences using ecological momentary assessment. Emotion 2020, 20, 30–36. [CrossRef]
7. Beute, F.; De Kort, Y.; Ijsselsteijn, W. Restoration in its natural context: How ecological momentary assessment
can advance restoration research. Int. J. Environ. Res. Public Health 2016, 13, 420. [CrossRef]
8. Kendrick, T.; Moore, M.; Gilbody, S.; Churchill, R.; Stuart, B.; El-Gohary, M. Routine use of patient reported
outcome measures (PROMs) for improving treatment of common mental health disorders in adults. Cochrane
Database Syst. Rev. 2014, 2014. [CrossRef]
9. Canadian Psychological Association. Outcomes and Progress Monitoring in Psychotherapy; A Report of the
Canadian Psychological Association, Prepared by the Task Force on Outcomes and Progress Monitoring in
Psychotherapy; Canadian Psychological Association: Ottawa, ON, Canada, 2018.
10. Knaup, C.; Koesters, M.; Schoefer, D.; Becker, T.; Puschner, B. Effect of feedback of treatment outcome in
specialist mental healthcare: Meta-analysis. Br. J. Psychiatry 2009, 195, 15–22. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 3170 20 of 22
11. Scott, K.; Lewis, C.C. Using measurement-based care to enhance any treatment. Cogn. Behav. Pract. 2015, 22,
49–59. [CrossRef]
12. Lambert, M.J.; Whipple, J.L.; Smart, D.W.; Vermeersch, D.A.; Nielsen, S.L.; Hawkins, E.J. The effects of
providing therapists with feedback on patient progress during psychotherapy: Are outcomes enhanced?
Psychother. Res. 2001, 11, 49–68. [CrossRef] [PubMed]
13. Goldberg, S.B.; Buck, B.; Raphaely, S.; Fortney, J.C. Measuring psychiatric symptoms remotely: A systematic
review of remote measurement-based care. Curr. Psychiatry Rep. 2018, 20, 81. [CrossRef] [PubMed]
14. Reese, R.J.; Norsworthy, L.A.; Rowlands, S.R. Does a continuous feedback system improve psychotherapy
outcome? Psychotherapy 2009, 46, 418–431. [CrossRef] [PubMed]
15. Lambert, M.J.; Harmon, C.; Slade, K.; Whipple, J.L.; Hawkins, E.J. Providing feedback to psychotherapists
on their patients’ progress: Clinical results and practice sugges tions. J. Clin. Psychol. 2005, 61, 165–174.
[CrossRef] [PubMed]
16. Bickman, L.; Kelley, S.D.; Breda, C.; De Andrade, A.R.; Riemer, M. Effects of routine feedback to clinicians
on mental health outcomes of youths: Results of a randomized trial. Psychiatr. Serv. 2011, 62, 1423–1429.
[CrossRef]
17. Carlier, I.V.E.; Meuldijk, D.; Van Vliet, I.M.; Van Fenema, E.; Van Der Wee, N.J.A.; Zitman, F.G. Routine
outcome monitoring and feedback on physical or mental health status: Evidence and theory. J. Eval. Clin.
Pract. 2012, 18, 104–110. [CrossRef]
18. Gondek, D.; Edbrooke-Childs, J.; Fink, E.; Deighton, J.; Wolpert, M. Feedback from outcome measures and
treatment effectiveness, treatment efficiency, and collaborative practice: A systematic review. Adm. Policy
Ment. Health Ment. Health Serv. Res. 2016, 43, 325–343. [CrossRef]
19. Imel, Z.E.; Caperton, D.D.; Tanana, M.; Atkins, D.C. Technology-enhanced human interaction in
psychotherapy. J. Couns. Psychol. 2017, 64, 385–393. [CrossRef]
20. Aboraya, A.; Nasrallah, H.A.; Elswick, D.E.; Elshazly, A.; Estephan, N.; Aboraya, D.; Berzingi, S.; Chumbers, J.;
Berzingi, S.; Justice, J.; et al. Measurement-based care in psychiatry—Past, present, and future. Innov. Clin.
Neurosci. 2018, 15, 13–26.
21. Hallgren, K.A.; Bauer, A.M.; Atkins, D.C. Digital technology and clinical decision making in depression
treatment: Current findings and future opportunities. Depress. Anxiety 2017, 34, 494–501. [CrossRef]
22. Bauer, S.; Moessner, M. Technology-enhanced monitoring in psychotherapy and e-mental health. J. Ment.
Health 2012, 21, 355–363. [CrossRef] [PubMed]
23. Silk, J.S.; Forbes, E.E.; Whalen, D.J.; Jakubcak, J.L.; Thompson, W.K.; Ryan, N.D.; Axelson, D.A.; Birmaher, B.;
Dahl, R.E. Daily emotional dynamics in depressed youth: A cell phone ecological momentary assessment
study. J. Exp. Child Psychol. 2011, 110, 241–257. [CrossRef] [PubMed]
24. Suso-Ribera, C.; Castilla, D.; Zaragozá, I.; Ribera-Canudas, M.V.; Botella, C.; García-Palacios, A. Validity,
reliability, feasibility, and usefulness of Pain Monitor. A multidimensional smartphone app for daily
monitoring of adults with heterogeneous chronic pain. Clin. J. Pain 2018, 34, 900–908. [CrossRef] [PubMed]
25. Hegland, P.A.; Aasprang, A.; Hjelle Øygard, S.; Nordberg, S.; Kolotkin, R.; Moltu, C.; Tell, G.S.; Andersen, J.R.
A review of systematic reviews on the effects of patient-reported outcome monitoring with clinical feedback
systems on health-related quality of life-implications for a novel technology in obesity treatment. Clin. Obes.
2018, 8, 452–464. [CrossRef]
26. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Altman, D.G.; Antes, G.; Atkins, D.; Barbour, V.;
Barrowman, N.; Berlin, J.A.; et al. Preferred reporting items for systematic reviews and meta-analyses:
The PRISMA statement (Chinese edition). J. Chin. Integr. Med. 2009, 7, 889–896. [CrossRef]
27. Falagas, M.E.; Pitsouni, E.I.; Malietzis, G.A.; Pappas, G. Comparison of PubMed, Scopus, Web of Science,
and Google Scholar: Strengths and weaknesses. FASEB J. 2008, 22, 338–342. [CrossRef]
28. Eady, A.M.; Wilczynski, N.L.; Haynes, R.B. PsycINFO search strategies identified methodologically sound
therapy studies and review articles for use by clinicians and researchers. J. Clin. Epidemiol. 2008, 61, 34–40.
[CrossRef]
29. National Heart Lung and Blood Institute (NHLBI). Study Quality Assessment Tools. Available online:
https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed on 1 May 2020).
30. Smith, B.; Harms, W.D.; Burres, S.; Korda, H.; Rosen, H.; Davis, J. Enhancing behavioral health treatment and
crisis management through mobile ecological momentary assessment and SMS messaging. Health Inform. J.
2012, 18, 294–308. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 3170 21 of 22
31. Pramana, G.; Parmanto, B.; Kendall, P.C.; Silk, J.S. The SmartCAT: An m-health platform for ecological
momentary intervention in child anxiety treatment. Telemed. e-Health 2014, 20, 419–427. [CrossRef]
32. Pinsof, W.M.; Goldsmith, J.Z.; Latta, T.A. Information technology and feedback research can bridge the
scientist–practitioner gap: A couple therapy example. Couple Fam. Psychol. Res. Pract. 2012, 1, 253–273.
[CrossRef]
33. Aguilera, A.; Bruehlman-Senecal, E.; Demasi, O.; Avila, P. Automated Text messaging as an adjunct to
cognitive behavioral therapy for depression: A clinical trial. J. Med. Internet Res. 2017, 19, e148. [CrossRef]
[PubMed]
34. Kumar, D.; Tully, L.M.; Iosif, A.-M.; Zakskorn, L.N.; Nye, K.E.; Zia, A.; Niendam, T.A. A mobile health
platform for clinical monitoring in early psychosis: Implementation in community-based outpatient early
psychosis care. JMIR Ment. Health 2018, 5, e15. [CrossRef] [PubMed]
35. Aharonovich, E.; Sarvet, A.; Stohl, M.; DesJarlais, D.; Tross, S.; Hurst, T.; Urbina, A.; Hasin, D. Reducing
non-injection drug use in HIV primary care: A randomized trial of brief motivational interviewing, with
and without HealthCall, a technology-based enhancement. J. Subst. Abuse Treat. 2017, 74, 71–79. [CrossRef]
[PubMed]
36. Niendam, T.A.; Tully, L.M.; Iosif, A.M.; Kumar, D.; Nye, K.E.; Denton, J.C.; Zakskorn, L.N.; Fedechko, T.L.;
Pierce, K.M. Enhancing early psychosis treatment using smartphone technology: A longitudinal feasibility
and validity study. J. Psychiatr. Res. 2018, 96, 239–246. [CrossRef]
37. Bauer, A.M.; Iles-Shih, M.; Ghomi, R.H.; Rue, T.; Grover, T.; Kincler, N.; Miller, M.; Katon, W.J. Acceptability
of mHealth augmentation of Collaborative Care: A mixed methods pilot study. Gen. Hosp. Psychiatry 2018,
51, 22–29. [CrossRef]
38. Bell, I.H.; Rossell, S.L.; Farhall, J.; Hayward, M.; Lim, M.H.; Fielding-Smith, S.F.; Thomas, N. Pilot randomised
controlled trial of a brief coping-focused intervention for hearing voices blended with smartphone-based
ecological momentary assessment and intervention (SAVVy): Feasibility, acceptability and preliminary
clinical outcomes. Schizophr. Res. 2019. [CrossRef]
39. Bell, I.H.; Fielding-Smith, S.F.; Hayward, M.; Rossell, S.L.; Lim, M.H.; Farhall, J.; Thomas, N.
Smartphone-based ecological momentary assessment and intervention in a blended coping-focused therapy
for distressing voices: Development and case illustration. Internet Interv. 2018, 14, 18–25. [CrossRef]
40. Newnham, E.A.; Hooke, G.R.; Page, A.C. Progress monitoring and feedback in psychiatric care reduces
depressive symptoms. J. Affect. Disord. 2010, 127, 139–146. [CrossRef]
41. Delgadillo, J.; Overend, K.; Lucock, M.; Groom, M.; Kirby, N.; McMillan, D.; Gilbody, S.; Lutz, W.; Rubel, J.A.;
De Jong, K. Improving the efficiency of psychological treatment using outcome feedback technology. Behav.
Res. Ther. 2017, 99, 89–97. [CrossRef]
42. Delgadillo, J.; De Jong, K.; Lucock, M.; Lutz, W.; Rubel, J.; Gilbody, S.; Ali, S.; Aguirre, E.; Appleton, M.;
Nevin, J.; et al. Feedback-informed treatment versus usual psychological treatment for depression and
anxiety: A multisite, open-label, cluster randomised controlled trial. Lancet Psychiatry 2018, 5, 564–572.
[CrossRef]
43. Miklowitz, D.J.; Price, J.; Holmes, E.A.; Rendell, J.; Bell, S.; Budge, K.; Christensen, J.; Wallace, J.; Simon, J.;
Armstrong, N.M.; et al. Facilitated Integrated Mood Management for adults with bipolar disorder. Bipolar
Disord. 2012, 14, 185–197. [CrossRef] [PubMed]
44. Schiepek, G.; Aichhorn, W.; Gruber, M.; Strunk, G.; Bachler, E.; Aas, B. Real-time monitoring of
psychotherapeutic processes: Concept and compliance. Front. Psychol. 2016, 7, 604. [CrossRef] [PubMed]
45. Kaiser, T.; Laireiter, A.R. DynAMo: A modular platform for monitoring process, outcome, and
algorithm-based treatment planning in psychotherapy. JMIR Med. Inform. 2017, 5, e20. [CrossRef]
[PubMed]
46. Lazarou, I.; Karakostas, A.; Stavropoulos, T.G.; Tsompanidis, T.; Meditskos, G.; Kompatsiaris, I.; Tsolaki, M.
A novel and intelligent home monitoring system for care support of elders with cognitive impairment.
J. Alzheimer’s Dis. 2016, 54, 1561–1591. [CrossRef] [PubMed]
47. De Jong, K.; Timman, R.; Hakkaart-Van Roijen, L.; Vermeulen, P.; Kooiman, K.; Passchier, J.; Van Busschbach, J.
The effect of outcome monitoring feedback to clinicians and patients in short and long-term psychotherapy:
A randomized controlled trial. Psychother. Res. 2014, 24, 629–639. [CrossRef]
Int. J. Environ. Res. Public Health 2020, 17, 3170 22 of 22
48. Amble, I.; Gude, T.; Stubdal, S.; Andersen, B.J.; Wampold, B.E. The effect of implementing the Outcome
Questionnaire-45.2 feedback system in Norway: A multisite randomized clinical trial in a naturalistic setting.
Psychother. Res. 2015, 25, 669–677. [CrossRef]
49. Janse, P.D.; De Jong, K.; Van Dijk, M.K.; Hutschemaekers, G.J.M.; Verbraak, M.J.P.M. Improving the efficiency
of cognitive-behavioural therapy by using formal client feedback. Psychother. Res. 2017, 27, 525–538.
[CrossRef]
50. Lucock, M.; Halstead, J.; Leach, C.; Barkham, M.; Tucker, S.; Randal, C.; Middleton, J.; Khan, W.; Catlow, H.;
Waters, E.; et al. A mixed-method investigation of patient monitoring and enhanced feedback in routine
practice: Barriers and facilitators. Psychother. Res. 2015, 25, 633–646. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
